Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432349 · ClinicalTrials.gov registry record
Rett Syndrome Registry
A clinical trial of Genetic Disease and Neurodevelopmental Disorders, sponsored by International Rett Syndrome Foundation.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 18
- Study locations
NCT05432349 is a study of Genetic Disease and Neurodevelopmental Disorders that is actively recruiting participants, run by International Rett Syndrome Foundation. The registered enrollment target is 3,000 participants, above the 2,461-participant average among 30 other Genetic Disease trials with a reported enrollment target (22% higher). The trial reports 18 study locations across 15 states.
The verdict
NCT05432349, a study of Genetic Disease and Neurodevelopmental Disorders, is actively recruiting participants, sponsored by International Rett Syndrome Foundation.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 18
- Study locations
Study Summary
The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as reported by the Rett syndrome experts and by the caregivers of individuals with Rett syndrome. This study will be used to develop consensus based guidelines for the care of your loved ones with Rett syndrome and to facilitate the development of better clinical trials and other aspects of the drug development path for Rett syndrome.
Conditions Studied
Study Locations (18)
California
- Children's Hospital Los Angeles - Los Angeles
- UCSF Benioff Children's Hospital - Oakland
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
Texas
- Children's Health - Dallas
- Texas Children's Hospital - Houston
Alabama
- University of Alabama - Birmingham
Colorado
- Children's Hospital Colorado - Denver
Illinois
- Rush University Medical Center - Chicago
Maryland
- Kennedy Krieger Institute - Baltimore
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2028-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05432349
The ClinicalTrials.gov registry entry for NCT05432349 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,461-participant average among 30 other Genetic Disease trials with a reported enrollment target (22% higher). The listed sponsor is International Rett Syndrome Foundation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05432349 reports 18 study locations spanning 15 distinct geographic areas - top geographies include California, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT05432349 about?
NCT05432349 is a clinical study titled "Rett Syndrome Registry". The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as ...
What is the current status of trial NCT05432349?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2022-08-02. Estimated completion is 2028-07.
What conditions does trial NCT05432349 study?
This clinical trial studies the following conditions: Genetic Disease, Neurodevelopmental Disorders, Intellectual Disability, Nervous System Diseases, Rett Syndrome.
Who is sponsoring clinical trial NCT05432349?
This trial is sponsored by International Rett Syndrome Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432349 being conducted?
This trial has 18 study locations across Alabama, California, Colorado, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
-
Follow-up With Preimplantation Genetic Testing Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.